SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India’s Q3 consolidated net rises by 42%

25 Jan 2012 Evaluate

Granules India has reported results for its third quarter ended December 31, 2011.

The company’s net profit declined by 4.94%, to Rs 5.96 crore in the third quarter ended December 31, 2011 compared with Rs 6.27 crore in the year-ago period. Net sales grew 41.20% to Rs 155.56 crore in the quarter under review as compared with Rs 110.17 crore in the same quarter last year.

The company’s consolidated net profit increased 41.92%, to Rs 7.99 crore in the third quarter ended December 31, 2011 compared with Rs 5.63 crore in the year-ago period. Net sales grew 45% to Rs 185.72 crore in the quarter under review as compared with Rs 128 crore in the same quarter last year. 

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×